Enovix Co. (NASDAQ:ENVX – Get Free Report) saw some unusual options trading on Tuesday. Stock investors purchased 43,106 call options on the stock. This represents an increase of approximately 61% compared to the typical daily volume of 26,838 call options.
Wall Street Analyst Weigh In
ENVX has been the subject of a number of research reports. Cantor Fitzgerald reiterated an “overweight” rating and issued a $30.00 price objective on shares of Enovix in a report on Wednesday, October 30th. Benchmark reaffirmed a “buy” rating and set a $25.00 price target on shares of Enovix in a research note on Wednesday, October 30th. JPMorgan Chase & Co. cut their price target on shares of Enovix from $18.00 to $15.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd. Finally, Janney Montgomery Scott downgraded Enovix from a “buy” rating to a “neutral” rating and set a $10.00 price objective for the company. in a report on Thursday, October 31st. Two equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $20.50.
View Our Latest Analysis on Enovix
Enovix Trading Down 14.7 %
Enovix (NASDAQ:ENVX – Get Free Report) last released its quarterly earnings data on Tuesday, October 29th. The company reported ($0.17) earnings per share for the quarter, beating the consensus estimate of ($0.20) by $0.03. Enovix had a negative net margin of 1,180.21% and a negative return on equity of 102.19%. The company had revenue of $4.30 million during the quarter, compared to analyst estimates of $4.11 million. During the same quarter in the previous year, the business posted ($0.27) EPS. Research analysts expect that Enovix will post -1.17 earnings per share for the current year.
Insider Activity
In other news, insider Arthi Chakravarthy sold 35,000 shares of the firm’s stock in a transaction that occurred on Monday, October 14th. The shares were sold at an average price of $13.00, for a total value of $455,000.00. Following the sale, the insider now directly owns 343,305 shares in the company, valued at approximately $4,462,965. This trade represents a 9.25 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Betsy S. Atkins sold 75,000 shares of the company’s stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $9.73, for a total transaction of $729,750.00. Following the transaction, the director now owns 99,497 shares of the company’s stock, valued at approximately $968,105.81. This represents a 42.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 15.70% of the company’s stock.
Hedge Funds Weigh In On Enovix
Institutional investors have recently made changes to their positions in the stock. B. Riley Wealth Advisors Inc. bought a new stake in Enovix in the 3rd quarter valued at about $117,000. Franklin Resources Inc. grew its stake in Enovix by 81.4% in the third quarter. Franklin Resources Inc. now owns 79,559 shares of the company’s stock valued at $743,000 after acquiring an additional 35,711 shares during the period. Sanctuary Advisors LLC increased its holdings in shares of Enovix by 37.2% during the third quarter. Sanctuary Advisors LLC now owns 165,703 shares of the company’s stock valued at $1,563,000 after acquiring an additional 44,956 shares in the last quarter. Virtu Financial LLC acquired a new position in shares of Enovix during the third quarter worth approximately $205,000. Finally, Geode Capital Management LLC lifted its holdings in shares of Enovix by 5.4% in the 3rd quarter. Geode Capital Management LLC now owns 3,583,685 shares of the company’s stock worth $33,477,000 after purchasing an additional 182,757 shares in the last quarter. Institutional investors and hedge funds own 50.92% of the company’s stock.
Enovix Company Profile
Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Read More
- Five stocks we like better than Enovix
- Best Aerospace Stocks Investing
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- What is Put Option Volume?
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- Are Penny Stocks a Good Fit for Your Portfolio?
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.